Global Nano-Bioengineering Diagnostics for Rare Diseases Market Research Report – Segmented By Technology (Nano Imaging Techniques, Nano Biosensors, Nanofluidics, Others), By Nanoparticles (Polymeric Nanoparticles, Metallic Nanoparticles, Carbon-based Nanoparticles, Nanoparticles functionalized with Biomolecules), By Application (Infectious diseases, Neurological disease, Cancer diseases, Cardiovascular diagnostics, Others), and Region- Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15735
Format:
Region: Global
Chapter 1. Nano-Bioengineering Diagnostics for Rare Diseases Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Nano-Bioengineering Diagnostics for Rare Diseases Market– Executive Summary
2.1 Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Nano-Bioengineering Diagnostics for Rare Diseases Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Nano-Bioengineering Diagnostics for Rare Diseases Market Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Nano-Bioengineering Diagnostics for Rare Diseases Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Nano-Bioengineering Diagnostics for Rare Diseases Market – By Technology
6.1 Introduction/Key Findings
6.2 Nano Imaging Techniques
6.3 Nano Biosensors
6.4 Nanofluidics
6.5 Others
6.6 Y-O-Y Growth trend Analysis By Technology
6.7 Absolute $ Opportunity Analysis By Technology, 2023-2030
Chapter 7. Nano-Bioengineering Diagnostics for Rare Diseases Market – By Nanoparticles
7.1 Introduction/Key Findings
7.2 Polymeric Nanoparticles
7.3 Metallic Nanoparticles
7.4 Carbon-based Nanoparticles
7.5 Nanoparticles functionalized with Biomolecules
7.6 Y-O-Y Growth trend Analysis By Nanoparticles
7.7 Absolute $ Opportunity Analysis By Nanoparticles, 2023-2030
Chapter 8. Nano-Bioengineering Diagnostics for Rare Diseases Market – By Application
8.1 Introduction/Key Findings
8.2 Infectious diseases
8.3 Neurological disease
8.4 Cancer diseases
8.5 Cardiovascular diagnostics
8.6 Others
8.7 Y-O-Y Growth trend Analysis Application
8.8 Absolute $ Opportunity Analysis Application, 2023-2030
Chapter 9. Nano-Bioengineering Diagnostics for Rare Diseases Market, By Geography – Market Size, Forecast, Trends & Insights
9.1 North America
9.1.1 By Country
9.1.1.1 U.S.A.
9.1.1.2 Canada
9.1.1.3 Mexico
9.1.2 By Technology
9.1.3 By Nanoparticles
9.1.4 By Application
9.1.5 Countries & Segments - Market Attractiveness Analysis
9.2 Europe
9.2.1 By Country
9.2.1.1 U.K
9.2.1.2 Germany
9.2.1.3 France
9.2.1.4 Italy
9.2.1.5 Spain
9.2.1.6 Rest of Europe
9.2.2 By Technology
9.2.3 By Nanoparticles
9.2.4 By Application
9.2.5 Countries & Segments - Market Attractiveness Analysis
9.3 Asia Pacific
9.3.1 By Country
9.3.1.1 China
9.3.1.2 Japan
9.3.1.3 South Korea
9.3.1.4 India
9.3.1.5 Australia & New Zealand
9.3.1.6 Rest of Asia-Pacific
9.3.2 By Technology
9.3.3 By Nanoparticles
9.3.4 By Application
9.3.5 Countries & Segments - Market Attractiveness Analysis
9.4 South America
9.4.1 By Country
9.4.1.1 Brazil
9.4.1.2 Argentina
9.4.1.3 Colombia
9.4.1.4 Chile
9.4.1.5 Rest of South America
9.4.2 By Technology
9.4.3 By Nanoparticles
9.4.4 By Application
9.4.5 Countries & Segments - Market Attractiveness Analysis
9.5 Middle East & Africa
9.5.1 By Country
9.5.1.1 United Arab Emirates (UAE)
9.5.1.2 Saudi Arabia
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 South Africa
9.5.1.6 Nigeria
9.5.1.7 Kenya
9.5.1.8 Egypt
9.5.1.9 Rest of MEA
9.5.2 By Technology
9.5.3 By Nanoparticles
9.5.4 By Application
9.5.5 Countries & Segments - Market Attractiveness Analysis
Chapter 10. Nano-Bioengineering Diagnostics for Rare Diseases Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1 Nano Diagnostic Technologies LLC
10.2 Nano4 Global
10.3 Luminex Corporation
10.4 Celgene Corporation
10.5 Sigma-Aldrich
10.6 Ablynx
10.7 Stryker Corporation
10.8 3M Company
10.9 NanoBiotix
10.10 SkyePharma Pharmaceuticals
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The Global Nano-Bioengineering Diagnostics for Rare Diseases Market was valued at USD 1.8 Billion and is projected to reach a market size of USD 5.2 Billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 14.2%.
Advancements in technology and increasing investments and research in this field are the market drivers.
Based on Technology, the Global Nano-Bioengineering Diagnostics for Rare Disease is segmented into Nano Imaging Techniques, Nano Biosensors, Nanofluidics, and Others.
The United States of America is the most dominant country in the region of North America for the Global Nano-Bioengineering Diagnostics for Rare Disease.
Nano Diagnostic Technologies LLC, Nano4 Global, Luminex Corporation, Celgene Corporation, Sigma-Aldrich, Ablynx, Stryker Corporation, 3M Company, NanoBiotix, SkyePharma Pharmaceuticals
